Immuto Scientific to Present New Conformational Target Landscape in TKI-Resistant Non-Small Cell Lung Cancer at Inaugural AACR Drug Discovery and Development Conference

Immuto Scientific said it will present new Structural Surfaceomics data for TKI-resistant non-small cell lung cancer at the inaugural AACR D3 Conference. The article provides no quantitative results or timeline/endpoint readout, implying limited near-term impact beyond incremental scientific/customer-visibility.

Analysis

Immuto Scientific said it will present new Structural Surfaceomics data for TKI-resistant non-small cell lung cancer at the inaugural AACR D3 Conference. The article provides no quantitative results or timeline/endpoint readout, implying limited near-term impact beyond incremental scientific/customer-visibility.